/https%3A%2F%2Fcongresse-me.s3.amazonaws.com%2Fglg7lpaq2r6h190m44xlf0y8sul3%3Fresponse-content-disposition%3Dinline%253B%2520filename%253D%2522logo%2520superior.png%2522%253B%2520filename%252A%253DUTF-8%2527%2527logo%252520superior.png%26response-content-type%3Dimage%252Fpng%26X-Amz-Algorithm%3DAWS4-HMAC-SHA256%26X-Amz-Credential%3DAKIA3W5H4K55MRVYNJ7U%252F20260221%252Fus-east-1%252Fs3%252Faws4_request%26X-Amz-Date%3D20260221T092934Z%26X-Amz-Expires%3D60%26X-Amz-SignedHeaders%3Dhost%26X-Amz-Signature%3D22fbf372c2eda3eb94ac6f31eb02d999be51eea10e0ea26e88523de41e4e746e)
Sobre o evento
O evento "Lorlatinibe em Foco" tem como objetivo central educar médicos oncologistas não generalistas sobre a recente indicação de Lorlatinibe como terapia de 1ª linha no tratamento oncológico.
Durante o evento, contaremos com a participação speakers, que compartilharão suas perspectivas sobre os benefícios da prescrição de Lorlatinibe.
Serão discutidos não apenas os efeitos terapêuticos e a eficácia do tratamento, mas também a análise das reações adversas associadas, evidenciando como Lorlatinibe apresenta um perfil de segurança favorável.
Nosso objetivo é proporcionar uma compreensão clara dos benefícios em prescrever Lorlatinibe como terapia de 1ª linha, capacitando os médicos a oferecerem um tratamento mais eficaz e com menor impacto negativo na qualidade de vida dos pacientes.
Evento PRESENCIAL.
Endereço:
📍 Espaço Fairbanks
Al. Raja Gabaglia, 177 - Vl. Olímpia | São Paulo / SP
Palestrantes
/https%3A%2F%2Fcongresse-me.s3.amazonaws.com%2F8zxdetxgo0xwgg1rwv6ase0j8elk%3Fresponse-content-disposition%3Dinline%253B%2520filename%253D%2522petros.png%2522%253B%2520filename%252A%253DUTF-8%2527%2527petros.png%26response-content-type%3Dimage%252Fpng%26X-Amz-Algorithm%3DAWS4-HMAC-SHA256%26X-Amz-Credential%3DAKIA3W5H4K55MRVYNJ7U%252F20260221%252Fus-east-1%252Fs3%252Faws4_request%26X-Amz-Date%3D20260221T092935Z%26X-Amz-Expires%3D60%26X-Amz-SignedHeaders%3Dhost%26X-Amz-Signature%3D4584381382d3ff829038eeaed0271cf51aa63a655a9560820b753b57fcd471c7)
Dr. Petros Christopoulos
Professor de Medicina na Universidade de Heidelberg, Hematologista e Oncologista no Centro Nacional de Doenças Tumorais Saiba mais
/https%3A%2F%2Fcongresse-me.s3.amazonaws.com%2F2qh3ioum7rr33go1esomqmz2jjjy%3Fresponse-content-disposition%3Dinline%253B%2520filename%253D%2522guilherme.png%2522%253B%2520filename%252A%253DUTF-8%2527%2527guilherme.png%26response-content-type%3Dimage%252Fpng%26X-Amz-Algorithm%3DAWS4-HMAC-SHA256%26X-Amz-Credential%3DAKIA3W5H4K55MRVYNJ7U%252F20260221%252Fus-east-1%252Fs3%252Faws4_request%26X-Amz-Date%3D20260221T092936Z%26X-Amz-Expires%3D60%26X-Amz-SignedHeaders%3Dhost%26X-Amz-Signature%3D03dd15d09d6bd22a23de48ce55f65ba0b01a25b68adcfe1be08c6044ef1d4ecf)
Dr. Guilherme Harada
Médico Oncologista | Coordenador de pesquisa Clínica em Oncologia do Hospital Sírio Libanês Saiba mais
/https%3A%2F%2Fcongresse-me.s3.amazonaws.com%2Faol6xoub517ou3opjhwgcdbwlofb%3Fresponse-content-disposition%3Dinline%253B%2520filename%253D%2522ale.png%2522%253B%2520filename%252A%253DUTF-8%2527%2527ale.png%26response-content-type%3Dimage%252Fpng%26X-Amz-Algorithm%3DAWS4-HMAC-SHA256%26X-Amz-Credential%3DAKIA3W5H4K55MRVYNJ7U%252F20260221%252Fus-east-1%252Fs3%252Faws4_request%26X-Amz-Date%3D20260221T092936Z%26X-Amz-Expires%3D60%26X-Amz-SignedHeaders%3Dhost%26X-Amz-Signature%3D008a701aab17994fb58ab190e59a8e8f011f7ebc6f66d6290e1bf2f6d0050804)
Dr. Alexandre Shoji
Chefe do departamento de psiquiatria geriátrica da Santa Casa de Misericórdia de SP e no A.C. Camargo Câncer Center Saiba mais
/https%3A%2F%2Fcongresse-me.s3.amazonaws.com%2Fpbhalpdmo30a0hhegfiuetb669xd%3Fresponse-content-disposition%3Dinline%253B%2520filename%253D%2522caarol.png%2522%253B%2520filename%252A%253DUTF-8%2527%2527caarol.png%26response-content-type%3Dimage%252Fpng%26X-Amz-Algorithm%3DAWS4-HMAC-SHA256%26X-Amz-Credential%3DAKIA3W5H4K55MRVYNJ7U%252F20260221%252Fus-east-1%252Fs3%252Faws4_request%26X-Amz-Date%3D20260221T092937Z%26X-Amz-Expires%3D60%26X-Amz-SignedHeaders%3Dhost%26X-Amz-Signature%3D331eb6ee45878442dbc012394ebfefae00cb515250a48da762fe43526e0f4c8c)
Contagem regressiva iniciada!
05/08
Inscreva-se
Em breve, estaremos juntos no Lorlatinibe em Foco, um dos eventos mais relevantes sobre inovação no tratamento oncológico.
Já confirmou sua presença?
Em breve, estaremos juntos no Lorlatinibe em Foco, um dos eventos mais relevantes sobre inovação no tratamento oncológico.
Já confirmou sua presença?
Já confirmou sua presença?
Programação
(sujeita a alterações)
05/08/25
Fuso horário do evento (faça login para alterar): Brasilia (GMT-03:00)
/https%3A%2F%2Fcongresse-me.s3.amazonaws.com%2Fehqufgcfm7kc2g7kl1l6w8gt7ufm%3Fresponse-content-disposition%3Dinline%253B%2520filename%253D%2522credenciamento.png%2522%253B%2520filename%252A%253DUTF-8%2527%2527credenciamento.png%26response-content-type%3Dimage%252Fpng%26X-Amz-Algorithm%3DAWS4-HMAC-SHA256%26X-Amz-Credential%3DAKIA3W5H4K55MRVYNJ7U%252F20260221%252Fus-east-1%252Fs3%252Faws4_request%26X-Amz-Date%3D20260221T092937Z%26X-Amz-Expires%3D60%26X-Amz-SignedHeaders%3Dhost%26X-Amz-Signature%3D216a30ecfcaf13e929dc4dd875baad6e4f865375eedf23b82547cc76e0cdae66)
/https%3A%2F%2Fcongresse-me.s3.amazonaws.com%2Feo6x1ut6rvbxyu7jw6fr0pmqwqf0%3Fresponse-content-disposition%3Dinline%253B%2520filename%253D%2522abertura.png%2522%253B%2520filename%252A%253DUTF-8%2527%2527abertura.png%26response-content-type%3Dimage%252Fpng%26X-Amz-Algorithm%3DAWS4-HMAC-SHA256%26X-Amz-Credential%3DAKIA3W5H4K55MRVYNJ7U%252F20260221%252Fus-east-1%252Fs3%252Faws4_request%26X-Amz-Date%3D20260221T092937Z%26X-Amz-Expires%3D60%26X-Amz-SignedHeaders%3Dhost%26X-Amz-Signature%3D3bce0a672c607b2d05d4f306bc91af6efa02f7eb7e9c0145cf397bef668ea5c5)
/https%3A%2F%2Fcongresse-me.s3.amazonaws.com%2F3cq54xf8202y5y0zvwe86finciae%3Fresponse-content-disposition%3Dinline%253B%2520filename%253D%2522aula.png%2522%253B%2520filename%252A%253DUTF-8%2527%2527aula.png%26response-content-type%3Dimage%252Fpng%26X-Amz-Algorithm%3DAWS4-HMAC-SHA256%26X-Amz-Credential%3DAKIA3W5H4K55MRVYNJ7U%252F20260221%252Fus-east-1%252Fs3%252Faws4_request%26X-Amz-Date%3D20260221T092938Z%26X-Amz-Expires%3D60%26X-Amz-SignedHeaders%3Dhost%26X-Amz-Signature%3D931e358e0a40f613a47c43f59239e975a1c3b09727478ca2889b5a4fd4d30582)
/https%3A%2F%2Fcongresse-me.s3.amazonaws.com%2Fjiejjmxffhu2jl38h9uuwb8ecp7e%3Fresponse-content-disposition%3Dinline%253B%2520filename%253D%2522biomarcadores.png%2522%253B%2520filename%252A%253DUTF-8%2527%2527biomarcadores.png%26response-content-type%3Dimage%252Fpng%26X-Amz-Algorithm%3DAWS4-HMAC-SHA256%26X-Amz-Credential%3DAKIA3W5H4K55MRVYNJ7U%252F20260221%252Fus-east-1%252Fs3%252Faws4_request%26X-Amz-Date%3D20260221T092938Z%26X-Amz-Expires%3D60%26X-Amz-SignedHeaders%3Dhost%26X-Amz-Signature%3D65e6d6f4400fbca46e47f152393701037dc683587bddf408f8d8826ce6bd9725)
/https%3A%2F%2Fcongresse-me.s3.amazonaws.com%2Fb7q8rhq71grxnffag0lwuhauzsm1%3Fresponse-content-disposition%3Dinline%253B%2520filename%253D%2522mesa%2520red.png%2522%253B%2520filename%252A%253DUTF-8%2527%2527mesa%252520red.png%26response-content-type%3Dimage%252Fpng%26X-Amz-Algorithm%3DAWS4-HMAC-SHA256%26X-Amz-Credential%3DAKIA3W5H4K55MRVYNJ7U%252F20260221%252Fus-east-1%252Fs3%252Faws4_request%26X-Amz-Date%3D20260221T092938Z%26X-Amz-Expires%3D60%26X-Amz-SignedHeaders%3Dhost%26X-Amz-Signature%3Dbdb0003150a6ee5bc8cfb1d9e95bd6fad95b3127f4ea2d7601cf6f21d3bf3ae6)
/https%3A%2F%2Fcongresse-me.s3.amazonaws.com%2Ftpfnnav411dr4j7hjuprle8f20ld%3Fresponse-content-disposition%3Dinline%253B%2520filename%253D%2522casos.png%2522%253B%2520filename%252A%253DUTF-8%2527%2527casos.png%26response-content-type%3Dimage%252Fpng%26X-Amz-Algorithm%3DAWS4-HMAC-SHA256%26X-Amz-Credential%3DAKIA3W5H4K55MRVYNJ7U%252F20260221%252Fus-east-1%252Fs3%252Faws4_request%26X-Amz-Date%3D20260221T092939Z%26X-Amz-Expires%3D60%26X-Amz-SignedHeaders%3Dhost%26X-Amz-Signature%3D2b14d6ce7928da43cba46cac9c75b9ab7748ad78803740a53ec59f65d670282b)
/https%3A%2F%2Fcongresse-me.s3.amazonaws.com%2Fj61xfl8cjqgkg23i0f2kxyy5i1tg%3Fresponse-content-disposition%3Dinline%253B%2520filename%253D%2522perguntas.png%2522%253B%2520filename%252A%253DUTF-8%2527%2527perguntas.png%26response-content-type%3Dimage%252Fpng%26X-Amz-Algorithm%3DAWS4-HMAC-SHA256%26X-Amz-Credential%3DAKIA3W5H4K55MRVYNJ7U%252F20260221%252Fus-east-1%252Fs3%252Faws4_request%26X-Amz-Date%3D20260221T092939Z%26X-Amz-Expires%3D60%26X-Amz-SignedHeaders%3Dhost%26X-Amz-Signature%3Dc28340b080f5270cddcb0911eafc051dc92a005e98802f959750ea012df490f7)
/https%3A%2F%2Fcongresse-me.s3.amazonaws.com%2Fs28vth6z45pt29qb9yvqf043pwji%3Fresponse-content-disposition%3Dinline%253B%2520filename%253D%2522almoco.png%2522%253B%2520filename%252A%253DUTF-8%2527%2527almo%2525C3%2525A7o.png%26response-content-type%3Dimage%252Fpng%26X-Amz-Algorithm%3DAWS4-HMAC-SHA256%26X-Amz-Credential%3DAKIA3W5H4K55MRVYNJ7U%252F20260221%252Fus-east-1%252Fs3%252Faws4_request%26X-Amz-Date%3D20260221T092939Z%26X-Amz-Expires%3D60%26X-Amz-SignedHeaders%3Dhost%26X-Amz-Signature%3Dc854020be2f959f0f92cabda200c8685cd73d72090003397d51d2d1d87e1057b)